Sabra Health Care REIT SBRA

REIT - Specialty, Real Estate

$19.56

−0.20%

Market cap: $5B
PE: 75.2×; 10y median 26.7×
Forward PE: n/m; not a meaningful number
Price to FFO: 18.8×; its own FFO
Price to sales: 5.8×
EV/EBIT: 41.6×
Revenue, 12 months: $859.6M; +17% on a year ago
Net margin: 7.6%

Sabra Health Care REIT trades at 18.8× its funds from operations, the earnings measure REITs are valued on. Revenue was $859.6M over the last twelve months, up 17% on a year earlier with a 8% net margin.

Charts

Financials

Income statement for SBRA, by quarter
Income statement	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
	$161.6M+15%	$163.4M−1%	$166.7M+3%	$176.1M+9%	$178M+10%	$182.3M+12%	$183.5M+10%	$189.2M+7%	$190M+7%	$211.9M+16%	$221.8M+21%	$235.9M+25%
SG&A	$10.8M+11%	$16.7M+54%	$11.9M+13%	$12.7M+34%	$12.4M+15%	$13M−22%	$12.7M+7%	$12.5M−2%	$12.6M+1%	$15.9M+22%	$14.9M+17%	$16.8M+34%
	$11.9M	$46.3M+48%	$55M+152%	$53.6M+6%	$58.8M+393%	$73.4M+58%	$67.6M+23%	$78M+46%	$52.6M−11%	$54.9M−25%	$67.9M+1%	$5.7M−93%
Interest expense	$28.2M+4%	$27.9M+0%	$28.4M−1%	$29.3M+4%	$29.5M+5%	$28.1M+1%	$27.1M−5%	$27.5M−6%	$28.9M−2%	$28.9M+3%	$28.4M+5%	$29.8M+8%
Pre-tax income	−$14M−69%	$18.4M+427%	$27.3M	$24.3M+10%	$29.3M	$47.2M+156%	$40.5M+48%	$65.2M+168%	$21.7M−26%	$26M−45%	$39.4M−3%	−$26.8M
	$455K−21%	$493K+298%	$453K−38%	$437K+34%	−$265K	$380K−23%	$413K−9%	$497K+14%	$436K	$491K+29%	$526K+27%	$678K+36%
Net income	−$15.1M−70%	$17.2M	$26.3M	$24M+13%	$29.8M	$46.7M+172%	$40.3M+54%	$65.5M+173%	$22.5M−24%	$27.2M−42%	$40.9M+1%	−$25.2M
	−$0.07−68%	$0.07	$0.11	$0.10+11%	$0.13	$0.19+171%	$0.17+55%	$0.27+170%	$0.09−31%	$0.11−42%	$0.16−6%	−$0.10
	231.2M+0%	232.8M+1%	233.4M+1%	233.8M+1%	237M+3%	239.8M+3%	240.3M+3%	240.9M+3%	243.6M+3%	253.1M+6%	256M+7%	252.3M+5%

Operating income: 26 periods, Q1 FY20 to Q2 FY26: not printed by the filing, worked out from its own lines.

Net income: 4 periods, Q1 FY20 to Q1 FY21: not printed by the filing, worked out from its own lines.

EPS, diluted: 15 periods, Q4 FY11 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 11 periods, Q4 FY11 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY18 to Q4 FY22: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY23: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in REIT - Specialty nearest Sabra Health Care REIT's size, closest first.

Company	Market cap	PE	Its 10y median PE	P/S	Revenue growth	Net margin
SBRASabra Health Care REIT	$5B	75.2×	26.7×	5.8×	+17%	7.6%
KRGKite Realty Group Trust	$4.9B	15.2×	126×	6.1×	−6%	41.8%
PECOPhillips Edison	$4.9B	34.6×	76.2×	6.6×	+8%	19.1%
RITMRithm Capital	$5.2B	15.7×	7.8×	1.0×	−24%	9.0%
STWDStarwood Property Trust	$4.7B	21.3×	15.2×	2.3×	+12%	11.4%
OUTOUTFRONT Media	$5.5B	22.3×	25.0×	2.8×	+8%	12.7%
RYNRayonier	$5.5B	41.4×	34.6×	5.7×	+0%	7.8%
KRCKilroy Realty	$4.3B	26.2×	24.6×	4.0×	−4%	1.7%
EPRTEssential Properties Realty Trust	$5.8B	20.7×	25.4×	9.4×	+22%	43.5%
EPREPR Properties	$4.3B	17.9×	22.1×	5.8×	+4%	35.5%
APLEApple Hospitality REIT	$4.3B	24.4×	21.2×	3.0×	+1%	12.2%
Peer median	$4.9B	21.8×	24.8×	4.8×	+3%	12.4%